BRISTOL MYERS SQUIBB CO (BMY) revenue & profit
BRISTOL MYERS SQUIBB CO (BMY): revenue $48.2B, net income $7.1B in 2025; latest quarter +5.7% year over year. From SEC filings.
$48.2BRevenue 2025
TickerBMY (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$48.2B
Net income 2025$7.1B
Net margin14.6%
Annual revenue growth-0.2%
Latest quarter (2026 Q2) · Revenue$13B
vs. same quarter last year+5.7%
Latest quarter · Net income$3.3B
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $46.2B | $6.3B | |
| 2023 | $45B | $8B | |
| 2024 | $48.3B | -$8.9B | |
| 2025 | $48.2B | $7.1B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.